Literature DB >> 16232557

Rhodobacter sphaeroides mutants which accumulate 5-aminolevulinic acid under aerobic and dark conditions.

S Nishikawa1, K Watanabe, T Tanaka, N Miyachi, Y Hotta, Y Murooka.   

Abstract

The photosynthetic bacterium Rhodobacter sphaeroides accumulates 5-aminolevulinic acid (ALA), which is a precursor in tetrapyrrole biosynthesis, under light illumination and upon addition of levulinic acid as an inhibitor of ALA dehydratase. To generate an industrial strain which produces ALA in the absence of light, we sequentially mutated R. sphaeroides CR-286 using N-methyl-N'-nitro-N-nitrosoguanidine (NTG). The mutant strains were screened by cultivating in the absence of light and assayed for ALA by the Ehrlich reaction in a 96-well microtiter plate. The mutant strain CR-386, derived from R. sphaeroides CR-286, was selected as a mutant that exhibited significant ALA accumulation. While CR-286 required light illumination for ALA production, CR-386 was able to accumulate 1.5 mM ALA in the presence of 50 mM glucose, 60 mM glycine, 15 mM levulinic acid and 1.0% (w/v) yeast extract under conditions of agitation in the absence of light. The mutant strain CR-450, derived from strain CR-386, was selected further as a mutant that exhibited significant ALA accumulation but no accumulation of aminoacetone, analogue of ALA. CR-450 accumulated 3.8 mM ALA under the same conditions. In the presence of 50 mM glucose, 60 mM glycine, 5 mM levulinic acid and 1.0% (w/v) yeast extract, the mutant strain CR-520, derived from strain CR-450, and strain CR-606, derived from strain CR-520, accumulated 8.1 mM and 11.2 mM ALA, respectively. In batch fermentation, the strain CR-606 accumulated 20 mM ALA over 18 h after the addition of glycine, levulinic acid, glucose and yeast extract.

Entities:  

Year:  1999        PMID: 16232557     DOI: 10.1016/s1389-1723(99)80156-x

Source DB:  PubMed          Journal:  J Biosci Bioeng        ISSN: 1347-4421            Impact factor:   2.894


  6 in total

1.  Optimization of the heme biosynthesis pathway for the production of 5-aminolevulinic acid in Escherichia coli.

Authors:  Junli Zhang; Zhen Kang; Jian Chen; Guocheng Du
Journal:  Sci Rep       Date:  2015-02-26       Impact factor: 4.379

2.  Fine-Tuning of hemB Using CRISPRi for Increasing 5-Aminolevulinic Acid Production in Escherichia coli.

Authors:  Tianyuan Su; Qi Guo; Yi Zheng; Quanfeng Liang; Qian Wang; Qingsheng Qi
Journal:  Front Microbiol       Date:  2019-07-31       Impact factor: 5.640

3.  Possible Antiviral Activity of 5-Aminolevulinic Acid in Feline Infectious Peritonitis Virus (Feline Coronavirus) Infection.

Authors:  Tomomi Takano; Kumi Satoh; Tomoyoshi Doki
Journal:  Front Vet Sci       Date:  2021-02-10

4.  Metabolic engineering of Escherichia coli BW25113 for the production of 5-Aminolevulinic Acid based on CRISPR/Cas9 mediated gene knockout and metabolic pathway modification.

Authors:  Changchuan Ye; Yuting Yang; Xi Chen; Lijie Yang; Xia Hua; Mengjie Yang; Xiangfang Zeng; Shiyan Qiao
Journal:  J Biol Eng       Date:  2022-10-13       Impact factor: 6.248

5.  Engineering Corynebacterium glutamicum to produce 5-aminolevulinic acid from glucose.

Authors:  Xiaoli Yu; Haiying Jin; Wenjing Liu; Qian Wang; Qingsheng Qi
Journal:  Microb Cell Fact       Date:  2015-11-17       Impact factor: 5.328

6.  Efficient bioproduction of 5-aminolevulinic acid, a promising biostimulant and nutrient, from renewable bioresources by engineered Corynebacterium glutamicum.

Authors:  Jiuzhou Chen; Yu Wang; Xuan Guo; Deming Rao; Wenjuan Zhou; Ping Zheng; Jibin Sun; Yanhe Ma
Journal:  Biotechnol Biofuels       Date:  2020-03-10       Impact factor: 6.040

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.